FIELD: medicine.
SUBSTANCE: invention refers to dermatology and can be used in dermatological practice to treat patients with skin sarcoidosis. For this diprospan is used intradermally in single dose of 0.14-7.0 mg/cm with interval of 19-23 days between injections. The course is 3-5 injections. At the same time intramuscularly used longidase of 1500-3000 ME. Additionally in the middle of interval between injections of diprospane one-time longidase is used in the same dosage.
EFFECT: method allows elimination severe forms of skin sarcoidosis, sufficiently increase life quality, reduce psycoemotional consequences, reduce treatment terms and frequency of regression due to increase of treatment effectiveness by modulation non-specific immune resistance and reaching stable anti-inflammatory effect.
1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING IDIOPATHIC NEUTROPHIL LOBULAR PANNICULITIS | 2020 |
|
RU2729996C1 |
| METHOD OF TREATING MORPHEA | 2010 |
|
RU2424008C1 |
| METHOD OF INDIVIDUAL RECOVERY OF FUNCTIONAL ACTIVITY OF ADRENAL CORTEX IN PATIENTS WITH SOMATIC DISEASES WITH LONG HISTORY OF GLUCOCORTICOSTEROID THERAPY | 2010 |
|
RU2439563C1 |
| METHOD OF TREATING T-CELL LYMPHOMAS AND KAPOSIS'S SARCOMA | 2009 |
|
RU2401671C1 |
| METHOD OF DIAGNOSTICS OF AUTOIMMUNE VIOLENT DERMATOSES | 2008 |
|
RU2352947C1 |
| METHOD FOR PREVENTION OF CICATRICAL-SCLEROTIC COMPLICATIONS FOLLOWING SURGICAL MANAGEMENT OF UPPER URINARY TRACT | 2014 |
|
RU2564147C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
| METHOD OF PREVENTION OF CICATRICIAL SCLEROTIC COMPLICATIONS AFTER SURGICAL TREATMENT ON THE UPPER URINARY TRACT | 2017 |
|
RU2651093C1 |
